About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Cleveland | 11,559 Studies Near You

Clinical TrialsCleveland

Clinical Trials in Cleveland

Discover 11,559 clinical trials near Cleveland, Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1501-1520 of 11,559 trials

CompletedSafety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With HypoparathyroidismThe purpose of this study is to investigate the safety and tolerability of MBX 2109 administered once weekly to patients with hypoparathyroidism.NCT06465108·Sacramento, California and 32 others

Find Trials by Condition in Cleveland

Breast Cancerin Cleveland Lung Cancerin Cleveland Prostate Cancerin Cleveland Colorectal Cancerin Cleveland Melanomain Cleveland Leukemiain Cleveland Lymphomain Cleveland Pancreatic Cancerin Cleveland Ovarian Cancerin Cleveland Brain Cancerin Cleveland

Data from ClinicalTrials.govTerms

UnknownTruGraf® Long-term Clinical Outcomes StudyThis is a prospective, multi-center, observational study. Subjects will have OmniGraf™ (TruGraf® and TRAC™) testing at study enrollment and thereafter every 3 months.NCT04491552·Tucson, Arizona and 35 others

CompletedRESOLUTE ONYX Post-Approval StudyTo observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.NCT03063749·Huntsville, Alabama and 27 others

CompletedPeripheral Nerve Stimulation for Shoulder Pain: Dose ResponseThe primary objective of this RCT is explore the mechanism for Hemiplegic Shoulder Pain (HSP) reduction due to treatment with peripheral nerve stimulation.NCT02928055·Cleveland, Ohio

CompletedOPTIONS Spinal Cord Stimulation Programming ParametersThe purpose of this study is to evaluate programming options in spinal cord stimulation for the management of chronic, intractable pain of the trunk and limbs.NCT02503787·Scottsdale, Arizona and 10 others

CompletedNightWare Randomized Trial 02This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment…NCT04040387·Bethesda, Maryland and 3 others

CompletedA Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17This is a clinical study to assess the safety, tolerance and immunogenic response to Gardasil (human papilloma virus (HPV)) and rLP2086 vaccine.NCT01461993·Daphne, Alabama and 86 others

CompletedMORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaThis phase I trial studies the side effects and best dose of MORAb-004 in treating young patients with recurrent or refractory solid tumors or lymphoma.NCT01748721·Birmingham, Alabama and 19 others

CompletedA Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of AgeThe purpose of this study is to assess immune response and safety of various potencies of an investigational chickenpox vaccine given to healthy children 12 to 15 months of age.NCT05084508·Bryant, Arkansas and 50 others

CompletedChronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement StudyChronic kidney disease (CKD) is defined as kidney damage for greater than 3 months or a glomerular filtration rate less than 60 mL/min per 1.73m2 for greater than 3 months.NCT00921687·Cleveland, Ohio

CompletedA Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia AHaemophilia A is an inherited disorder in which one of the proteins, Factor VIII, needed to form blood clots is missing or not present in sufficient levels.NCT01580293·Tucson, Arizona and 58 others

CompletedCombination Adenovirus + Pembrolizumab to Trigger Immune Virus EffectsGlioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive forms of malignant brain tumor in adults and can be resistant to conventional therapies.NCT02798406·Little Rock, Arkansas and 14 others

RecruitingA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerThis is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and…NCT06532006·Anaheim, California and 207 others

CompletedA Multicenter Assessment of ALD403 in Chronic MigraineThe purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.NCT02275117·Huntsville, Alabama and 91 others

Active not recruitingA Prospective Observational Study of TPIATMulti-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)NCT03260387·San Francisco, California and 11 others

CompletedSerine and Fenofibrate Study in Patients With MacTel Type 2This is a Phase 2a study of the effect of serine supplementation and fenofibrate treatment on serum deoxysphingolipid levels in patients with macular telangiectasia type 2…NCT04907084·Atlanta, Georgia and 8 others

Active not recruitingA 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental VitiligoThis study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with non-segmental vitiligo.NCT06163326·Encinitas, California and 72 others

CompletedEvaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial FibrillationProspective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to demonstrate the safety and effectiveness when compared to an historical control…NCT03775512·Birmingham, Alabama and 21 others

CompletedStudy of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney TransplantationThis three-arm study will evaluate the efficacy and safety of various dosing regimens of MMF combined with various dosing regimens of calcineurin inhibitor (CNI), either…NCT00087581·Birmingham, Alabama and 56 others

TerminatedRandomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILDThe primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver…NCT02612428·Little Rock, Arkansas and 43 others

PreviousPage 76 of 578Next

Diabetes

in Cleveland

Heart Diseasein Cleveland